MedPath
NMPA Approval

Compound Fluorouracil Oral Solution

国药准字H23023199

July 22, 2020

Drug Information

复方氟尿嘧啶口服溶液

口服溶液剂

0.4%(氟尿嘧啶)

化学药品

July 22, 2020

Company Information

Applicant Company

Manufacturing Company

黑龙江省庆安县东城区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氟尿嘧啶口服溶液 - NMPA 批准文号 | MedPath